Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-02

Clinical Trial Update: RCT of Non-Invasive Vagus Nerve Stimulation (nVNS) With gammaCore®, for the Acute Treatment of Migraine Attacks [NA]

View source ↗

Summary

A completed clinical trial evaluating non-invasive vagus nerve stimulation (gammaCore) for acute treatment of migraine attacks; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • gammaCore

Snippet

Sponsor: ElectroCore INC | Conditions: Migraine | NA | Status: COMPLETED | Results posted: 2019-08-02